TY - JOUR
T1 - Deep Learning-Assisted Automated Single Cell Electroporation Platform for Effective Genetic Manipulation of Hard-to-Transfect Cells
AU - Mukherjee, Prithvijit
AU - Patino, Cesar A.
AU - Pathak, Nibir
AU - Lemaitre, Vincent
AU - Espinosa, Horacio D.
N1 - Funding Information:
Research reported in this publication was supported by NIH SBIR Phase 1 award number 1R43GM128500-01 and NIH R21 award number 1R21GM132709-01. This work utilized the Argonne National Lab Center for Nanoscale Materials. Use of the Center for Nanoscale Materials, an Office of Science user facility, was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract no. DE-AC02-06CH11357.
Funding Information:
Research reported in this publication was supported by NIH SBIR Phase 1 award number 1R43GM128500‐01 and NIH R21 award number 1R21GM132709‐01. This work utilized the Argonne National Lab Center for Nanoscale Materials. Use of the Center for Nanoscale Materials, an Office of Science user facility, was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract no. DE‐AC02‐06CH11357.
Publisher Copyright:
© 2022 The Authors. Small published by Wiley-VCH GmbH
PY - 2022
Y1 - 2022
N2 - Genome engineering of cells using CRISPR/Cas systems has opened new avenues for pharmacological screening and investigating the molecular mechanisms of disease. A critical step in many such studies is the intracellular delivery of the gene editing machinery and the subsequent manipulation of cells. However, these workflows often involve processes such as bulk electroporation for intracellular delivery and fluorescence activated cell sorting for cell isolation that can be harsh to sensitive cell types such as human-induced pluripotent stem cells (hiPSCs). This often leads to poor viability and low overall efficacy, requiring the use of large starting samples. In this work, a fully automated version of the nanofountain probe electroporation (NFP-E) system, a nanopipette-based single-cell electroporation method is presented that provides superior cell viability and efficiency compared to traditional methods. The automated system utilizes a deep convolutional network to identify cell locations and a cell-nanopipette contact algorithm to position the nanopipette over each cell for the application of electroporation pulses. The automated NFP-E is combined with microconfinement arrays for cell isolation to demonstrate a workflow that can be used for CRISPR/Cas9 gene editing and cell tracking with potential applications in screening studies and isogenic cell line generation.
AB - Genome engineering of cells using CRISPR/Cas systems has opened new avenues for pharmacological screening and investigating the molecular mechanisms of disease. A critical step in many such studies is the intracellular delivery of the gene editing machinery and the subsequent manipulation of cells. However, these workflows often involve processes such as bulk electroporation for intracellular delivery and fluorescence activated cell sorting for cell isolation that can be harsh to sensitive cell types such as human-induced pluripotent stem cells (hiPSCs). This often leads to poor viability and low overall efficacy, requiring the use of large starting samples. In this work, a fully automated version of the nanofountain probe electroporation (NFP-E) system, a nanopipette-based single-cell electroporation method is presented that provides superior cell viability and efficiency compared to traditional methods. The automated system utilizes a deep convolutional network to identify cell locations and a cell-nanopipette contact algorithm to position the nanopipette over each cell for the application of electroporation pulses. The automated NFP-E is combined with microconfinement arrays for cell isolation to demonstrate a workflow that can be used for CRISPR/Cas9 gene editing and cell tracking with potential applications in screening studies and isogenic cell line generation.
KW - CRISPR/Cas9
KW - deep learning
KW - human-induced pluripotent stem cells (hiPSCs)
KW - intracellular delivery
KW - single-cell electroporation
UR - http://www.scopus.com/inward/record.url?scp=85126757907&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85126757907&partnerID=8YFLogxK
U2 - 10.1002/smll.202107795
DO - 10.1002/smll.202107795
M3 - Article
C2 - 35315229
AN - SCOPUS:85126757907
JO - Small
JF - Small
SN - 1613-6810
ER -